Home » Topics » BioWorld Science

BioWorld Science
RSS

Safe intracerebroventricular doses of huperzine A determined in animals

July 9, 2001

Atridox receives approval in Switzerland

July 9, 2001

Heterocyclic compounds with activity at alpha1-adrenoceptors and several 5-HT receptors

July 9, 2001

Insulin sensitizer licensed out by Roche to Kowa

July 9, 2001

Tanabe Seiyaku licenses DDS technologies to aaiPharma

July 9, 2001

Drop in disease progression on Casodex reported in prostate cancer trial

July 9, 2001

Novartis sells rights to five CNS products to Mallinckrodt

July 9, 2001

Betatropin: a new approach to type 2 diabetes discussed at recent scientific meetings

July 9, 2001

First evidence that topical antisense drug penetrates psoriatic lesions

July 9, 2001

Positive Seroquel data presented at Conference on Bipolar Disorder

July 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...